Live Quote · NASDAQAXDXHealthcare· Medical - Devices

Accelerate Diagnostics, Inc.

$0.03 0.00%(+$0.00)
TickerSpark Score
58/100
Mixed
100
Valuation
50
Profitability
60
Growth
48
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXDX research report →

52-Week Range1% of range
Low
$0.01
Current
$0.03
High
$2.09
Company Overviewacceleratediagnostics.com

About the company

Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform.

CEO
Jack Phillips
IPO
1994
Employees
107
HQ
Tucson, AZ, US

Price Chart

-99.20% · this period
$2.02$1.01$0.01Jun 05Dec 04Jun 09
Valuation
Market Cap
$859.92K
P/E
-0.02
P/S
0.07
P/B
-0.01
EV/EBITDA
-1.56
Div Yield
0.00%
Profitability
Gross Margin
23.12%
Op Margin
-301.85%
Net Margin
-427.81%
ROE
131.82%
ROIC
-243.30%
Growth & Income
Revenue
$11.70M · -2.99%
Net Income
$-50,045,000 · 18.78%
EPS
$-2.15 · 56.48%
Op Income
$-35,310,000
FCF YoY
40.09%
Performance & Tape
52W High
$2.09
52W Low
$0.01
50D MA
$0.60
200D MA
$1.28
Beta
0.22
Avg Volume
1.86M

Get TickerSpark's AI analysis on AXDX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 10, 25NATHAN GILBERT Eother0
Apr 10, 25Shalhoub Paul Vincentother0
Apr 4, 25Phillips Jackother53,283
Apr 4, 25Phillips Jacksell25,343
Apr 4, 25Phillips Jackother53,283
Apr 4, 25Mertz Larry Michaelother4,298
Apr 4, 25Mertz Larry Michaelsell1,523
Apr 4, 25Mertz Larry Michaelother4,298
Apr 1, 25Patience Davidother20,000
Apr 1, 25Patience Davidsell6,816
Coverage · AXDX

Our AXDX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on AXDX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate AXDX report →
Internal Compare

Similar companies

Peers in the same neighborhood.